Hong Ping Yu
Förmögenhet: 22 M $ per 2026-05-31
Förmögenhet: 22 M $ per 2026-05-31
Hong Ping Yu is the founder of Abbisko Therapeutics Co., Ltd., founded in 2016, serving as Chief Scientific Officer.
Dr. Yu is the founder of Abbisko Cayman Ltd., founded in 2016, serving as Executive Director & Chief Scientific Officer.
Dr. Yu is currently Director at Abbisko Hong Kong Ltd. since 2018.
Formerly, Dr. Yu was Deputy General Manager at Hansoh Shanghai Pharmaceutical Co. Ltd. from 2011 to 2016.
Education includes a doctorate from the University of British Columbia in 2000, a graduate degree from Tsinghua University in 1994, and an undergraduate degree from Tsinghua University in 1991.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED 2,43 % | 2026-04-08 | 17 612 962 ( 2,43 % ) | 22 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Grundare | 2016-04-12 |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Grundare | 2016-04-12 |
Abbisko Hong Kong Ltd. | Direktör/Styrelseledamot | 2018-03-01 |
| Företag | Position | Slut |
|---|---|---|
Hansoh Shanghai Pharmaceutical Co. Ltd. | Företagsledare/Principal | 2016-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Abbisko Cayman Ltd.
Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Abbisko Hong Kong Ltd. | |
Hansoh Shanghai Pharmaceutical Co. Ltd. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån